Financials
Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 122 M101 M84 M84 M79 M83 M 330 M Research & development —————— — Operating income 292 M532 M237 M483 M354 M403 M 1.48 B Non-Operating Income, Total 5 M6 M8 M-24 M22 M-15 M -9 M Interest expense, net of interest capitalized 94 M107 M110 M112 M138 M144 M 504 M Non-Operating Income, excl. Interest Expenses -93 M-107 M-110 M-127 M-132 M-144 M -513 M Unusual income/expense 4 M6 M8 M-9 M16 M-15 M 0 Pretax income 357 M565 M229 M458 M320 M333 M 1.34 B Equity in earnings 154 M103 M94 M96 M89 M89 M 368 M Taxes 94 M30 M16 M30 M14 M8 M 68 M Non-controlling/minority interest 128 M408 M253 M421 M344 M202 M 1.22 B After tax other income/expense 36 M-19 M-12 M-16 M33 M-30 M -25 M Net income before discontinued operations -31 M84 M-40 M7 M-40 M123 M 50 M Discontinued operations 20 M38 M70 M76 M102 M-103 M 145 M Net income -11 M84 M30 M83 M62 M20 M 195 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -2 M92 M30 M86 M66 M20 M 202 M Basic earnings per share (Basic EPS) —————— — Diluted earnings per share (Diluted EPS) —————— — Average basic shares outstanding —————— — Diluted shares outstanding —————— — EBITDA 954 M794 M472 M713 M609 M646 M 2.44 B EBIT 634 M532 M237 M483 M353 M403 M 1.48 B Cost of revenue 11.27 B10.76 B9.76 B10.59 B9.33 B11.49 B 41.16 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 320 M262 M235 M230 M256 M243 M 964 M